Table 1.
Overview of the main functions and metabolic features of tissue macrophage populations
Macrophage type | Organ/system | Ontogeny | Main surface markers | Main functions | Main metabolic features | References |
---|---|---|---|---|---|---|
Alveolar macrophages | Lung | Fetal liver monocytes | CD11c+ SiglecF+ CXC3R1− | Surfactant clearance, phagocytosis of inhaled particles, immune sentinel functions | ↑OXPHOS/mitochondrial respiration, lipid catabolism, cholesterol handling (PPARγ, LXRα, C/EBPβ, VHL); ↓Glycolysis | [5, 6, 65–70, 74–83, 85–88] |
Interstitial macrophages | Lung | Adult bone marrow/blood monocytes | CXC3R1+ CD11b+ SiglecF− | Control of pathogens and infections, immune sentinel functions | Upon Mtb infection: ↑Glycolysis; ↓Mitochondrial respiration, fatty acid or cholesterol metabolism | [5, 65, 87, 88] |
Marginal zone macrophages | Spleen | Adult bone marrow/blood monocytes | SIGNR1+ | Removal of blood-borne antigens and pathogens | Their development and immune function is controlled by LXRα (and LXRβ) | [89–93] |
Marginal metallophilic macrophages | Spleen | Adult bone marrow/blood monocytes | CD169+ Sialoadhesin+ | Removal of blood-borne antigens and pathogens | Their development and immune function is controlled by LXRα (and LXRβ) | [89–93] |
Tingible body macrophages | Spleen | Adult bone marrow/blood monocytes | F4/80− CD68+ | B cell phagocytosis during germinal center reaction | To be investigated | [89, 90] |
Red pulp macrophages | Spleen | Yolk sac and fetal liver progenitors | F4/80+ VCAM1+ CD11blo | Clearance of erythrocytes, platelets and blood pathogens; iron recycling; immune sentinel functions | ↑Iron metabolism (Spi-C, NRF2, HO-1), lipid and cholesterol handling (PPARγ, LXRα) | [3, 4, 66, 70, 89, 90, 95,99–107] |
Liver capsular macrophages | Liver | Adult bone marrow/blood monocytes | F4/80+ CX3CR1+ MHCII+ | Immune surveillance, neutrophil recruitment | ↓Metabolic gene signatures compared with Kupffer cells | [94, 95, 98] |
Kupffer cells | Liver | Fetal liver monocytes | F4/80+ Clec4F+ Tim4+ | Clearance of erythrocytes and blood pathogens; iron metabolism; mediators of immunological tolerance | ↑Iron metabolism (Spi-C, NRF2, HO-1), lipid and cholesterol handling (PPARγ, LXRα); ↓Glycolysis (upregulated upon stimulation) | [3, 4, 7, 70, 91, 94–104, 106, 107, 109] |
Erythroid island macrophages | Bone marrow | Adult bone marrow and fetal liver (likely) | F4/80+ VCAM1+ CD169+ | Support of erythropoiesis, iron handing | ↑Iron metabolism (Spi-C, HO-1) and fatty acid metabolism signatures | [106, 107] |
Small peritoneal macrophages | Peritoneum | Adult bone marrow/blood monocytes | F4/80-low CD11b-low MHCII-hi | Immune sentinel functions and inflammatory regulation | ↑Glycolysis and OXPHOS upon activation compared with large peritoneal macrophages | [110, 111] |
Large peritoneal macrophages | Peritoneum | Yolk sac progenitors | F4/80hi CD11bhi MHCIIlo | Clearance of dead cells/bacteria, inflammatory regulation, antimicrobial defense |
Naïve: ↑ETC/CII, ROS, lipid and cholesterol handling (GATA6, C/EBPβ, RXRα/β) Stimulated: context-dependent OXPHOS; ↓Lipid metabolism/FAO; ↑Glycolysis |
[70, 78–80, 86, 110–120] |
Microglia | Central nervous system | Yolk sac progenitors | F4/80+ CX3CR1+ CD11b+ | Immune sentinel functions; clearance of apoptotic cells; regulation of brain homeostasis, neurogenesis and synaptic activity |
Naïve: ↑OXPHOS, context-dependent fuel use (mainly glucose) and metabolic pathway activation Stimulated: ↑Glycolysis; ↓OXPHOS |
[121–126] |
Osteoclasts | Bone marrow, spleen, blood | Adult bone marrow/blood monocytes | TRAP+ (tartrate- resistant acid phosphatase) | Bone resorption (dissolution of collagen and mineralized bone) |
Naïve: ↑OXPHOS/CI activity, FAO, glutaminolysis Bone-exposed: ↑Glycolysis, HIF-1α, lactate production |
[128–135] |
Intestinal lamina propria macrophages | Intestine | Adult bone marrow/blood monocytes | CD64+ MHCIIhi CD206+ | Clearance of dead cells, maintenance of epithelial homeostasis, immune sentinel functions, antimicrobial activity |
Butyrate-exposed: ↑ROS production; Unaltered OXPHOS; ↓Glycolysis and mTOR signaling |
[136–138] |
Kidney-resident macrophages | Kidney | Yolk sac and/or fetal liver progenitors | CD64+ F4/80+ CD11c+ | Clearance of dead cells, likely regulation of ureteric bud branching and vascular development | ↑Fatty acid metabolism-, ↓OXPHOS- and glycolysis-related gene expression (healthy compared with lupus-like disease) | [116, 139, 140] |
White adipose tissue macrophages | Lean white adipose tissue | Yolk sac progenitors (predominantly) | F4/80+ CD11b+ CD206+ | Efferocytosis and apoptotic cell clearance | Metabolically quiescent (↓Glycolysis and ↓OXPHOS compared with macrophages from obese fat) | [189, 191, 196] |
Embryonic cardiac macrophages | Heart | Yolk sac and fetal liver progenitors |
CD64+ CX3CR1+ |
Efferocytosis and immune sentinel functions | Metabolically quiescent (↓Glycolysis and ↓OXPHOS compared with macrophages upon MI) | [141, 146] |
Monocyte-derived cardiac macrophages | Heart | Adult bone marrow/blood monocytes | CCR2+ MerTK+ CD64+ CD11chi CD206+ | Immune surveillance | ↑Glycolysis upon MI; ↑OXPHOS and ↓Glycolysis from Day 3 after MI. | [67, 141, 146] |
Skeletal muscle macrophages | Skeletal muscle | Embryonic and bone marrow precursors | CD11b+ F4/80+ CD64+ | Maintenance of tissue homeostasis, muscle growth and regeneration | To be investigated | [145] |